Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)-Reference-Cited by-同舟云学术

Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)

Published:2003-11 Issue:1 Volume:184 Page:536-548
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Eslamboli Andisheh,Cummings Rosalyn M,Ridley Rosalind M,Baker Harry F,Muzyczka Nicholas,Burger Corinna,Mandel Ronald J,Kirik Deniz,Annett Lucy E

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference43 articles.

1. The GDNF family;Airaksinen;Nat. Rev. Neurosci.,2002

2. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats;Andsberg;Neurobiol. Dis.,2002

3. Behavioural analysis of unilateral monoamine depletion in the marmoset;Annett;Brain,1992

4. The cryptic life style of adeno-associated virus;Berns;Bioessays,1995

5. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain;Chauhan;J. Chem. Neuroanat.,2001

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases;Biomedicines;2024-08-20

2. Neurotrophic Factors in Parkinson’s Disease: Clinical Trials;Stem Cell Biology and Regenerative Medicine;2024

3. Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease;Neurological Sciences;2023-12-12

4. Recent advances in the role of rehabilitative therapies for Parkinson’s disease: A literature review;Journal of Mind and Medical Sciences;2023-04-25

5. Pathological α-synuclein accumulation, CSF metabolites changes and brain microstructures in cynomolgus monkeys treated with 6-hydroxydopamine;NeuroToxicology;2023-01